Qinghua Zhou Selected Research

Qinghua Zhou Research Topics

Disease

139	Lung Neoplasms (Lung Cancer) 01/2024 - 02/2002
130	Neoplasms (Cancer) 05/2024 - 02/2002
86	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 08/2002
58	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2002
23	Adenocarcinoma of Lung 01/2024 - 04/2002
22	Carcinogenesis 01/2020 - 02/2002
9	Carcinoma (Carcinomatosis) 01/2021 - 04/2002
8	Adenocarcinoma 12/2021 - 04/2004
8	Prostatic Neoplasms (Prostate Cancer) 03/2013 - 04/2006
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 04/2004
4	Inflammation (Inflammations) 05/2024 - 04/2011
4	Lung Diseases (Lung Disease) 01/2024 - 02/2004
4	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2006
3	Circulating Neoplastic Cells 12/2023 - 11/2012
3	Disease Progression 07/2023 - 01/2016
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 04/2004
3	Wounds and Injuries (Trauma) 11/2022 - 12/2019
3	Lymphatic Metastasis 01/2022 - 04/2004
3	Liver Neoplasms (Liver Cancer) 01/2021 - 04/2006
3	Malignant Pleural Effusion 02/2019 - 10/2004
3	Exanthema (Rash) 08/2011 - 08/2004
2	Malignant Mesothelioma 05/2024 - 10/2023
2	Pneumonia (Pneumonitis) 01/2024 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2019
2	Non-alcoholic Fatty Liver Disease 10/2023 - 10/2021
2	Lewis Lung Carcinoma 01/2023 - 04/2004
2	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 11/2009
2	Obesity 12/2021 - 06/2019
2	Hepatocellular Carcinoma (Hepatoma) 07/2021 - 12/2009

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2004
20	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2008
16	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2010
15	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2002
14	Messenger RNA (mRNA)IBA 05/2024 - 04/2004
14	ErbB Receptors (EGF Receptor)IBA 11/2022 - 01/2009
12	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2009
10	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2020
9	CateninsIBA 01/2018 - 08/2002
8	Cadherins (E-Cadherin)IBA 09/2017 - 08/2002
7	Phosphotransferases (Kinase)IBA 08/2017 - 02/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2002
6	Gefitinib (Iressa)FDA Link 11/2022 - 08/2004
6	EnzymesIBA 01/2021 - 02/2005
5	CytokinesIBA 01/2023 - 03/2009
5	SmokeIBA 01/2023 - 04/2005
5	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 02/2005
5	Small Interfering RNA (siRNA)IBA 01/2017 - 05/2010
5	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2010 - 02/2002
4	LigandsIBA 01/2024 - 01/2018
4	Monoclonal AntibodiesIBA 01/2024 - 10/2006
4	ParaffinIBA 10/2023 - 08/2008
4	CarcinogensIBA 08/2022 - 06/2010
4	Long Noncoding RNAIBA 01/2021 - 01/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 02/2004
4	Nicotine FDA Link 04/2016 - 09/2011
4	Transcription Factors (Transcription Factor)IBA 04/2013 - 11/2009
4	SeleniumIBA 04/2012 - 04/2006
4	methylselenic acidIBA 04/2012 - 04/2006
4	EndostatinsIBA 08/2005 - 12/2002
3	B7-H1 AntigenIBA 03/2024 - 01/2022
3	AntibodiesIBA 01/2024 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2014
3	Formaldehyde (Formol)FDA Link 01/2023 - 08/2008
3	Complementary DNA (cDNA)IBA 01/2022 - 06/2005
3	AntigensIBA 01/2022 - 01/2011
3	Interleukin-6 (Interleukin 6)IBA 09/2017 - 08/2010
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2017 - 10/2010
3	LuciferasesIBA 06/2016 - 12/2004
3	Therapeutic UsesIBA 03/2016 - 10/2008
3	AndrogensIBA 03/2012 - 08/2010
3	Androgen Receptors (Androgen Receptor)IBA 02/2011 - 04/2010
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2010 - 12/2009
3	calphostin CIBA 06/2008 - 04/2004
3	tanshinoneIBA 04/2008 - 04/2002
3	hnRNP A2IBA 10/2006 - 04/2004
3	VaccinesIBA 01/2005 - 08/2002
3	Protein Kinases (Protein Kinase)IBA 10/2004 - 02/2004
2	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2024 - 07/2023
2	LipidsIBA 10/2023 - 10/2021
2	Liposomes (Liposome)IBA 01/2023 - 10/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2022 - 06/2011
2	Immunologic Factors (Immunomodulators)IBA 12/2021 - 01/2018
2	Coloring Agents (Dyes)IBA 12/2021 - 10/2009
2	Docetaxel (Taxotere)FDA Link 01/2021 - 03/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2017

Therapy/Procedure

46	Therapeutics 01/2024 - 12/2002
27	Drug Therapy (Chemotherapy) 01/2024 - 08/2002
18	Immunotherapy 05/2024 - 11/2018
11	Thoracotomy 11/2022 - 03/2010
8	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 05/2018
8	Radiotherapy 01/2023 - 08/2004
6	Neoadjuvant Therapy 07/2023 - 10/2009
6	Segmental Mastectomy (Lumpectomy) 01/2023 - 03/2019
6	Castration 03/2013 - 03/2010
3	Adjuvant Chemotherapy 01/2022 - 01/2013
3	Aftercare (After-Treatment) 03/2010 - 04/2004
2	Chemoprevention 11/2021 - 07/2011
2	Ligation 07/2021 - 12/2019
2	Contraindications 01/2021 - 02/2006
2	Transplantation 01/2021 - 08/2010